7
10, 2024
10
07, 2024
5
06, 2024
31
05, 2024
1
04, 2024
The Source Roundup: April 2024 Edition
Healthcare System Mergers and Investments Private Equity-Acquired Physician Practices and Market Penetration Increased Substantially, 2012-21 (Health Affairs) Ola Abdelhadi, Brent D. Fulton, Laura Alexander, and Richard M. Scheffler The awareness for private equity’s influence on the healthcare sector continues to grow and be quantified. Generally, there has been concern among parties in the health care system regarding the rate at which private equity firms have been acquiring physician practices, creating antitrust, quality, and pricing concerns within the broader health system. A new Health Affairs study estimated the local market share of private equity firms [...]
11
03, 2024
HB 165
An act relating to pharmaceutical drugs; requiring Medicaid managed care organizations to reimburse community-based pharmacy providers for the full cost of prescription drugs plus a professional dispensing fee; requiring the health care authority department to conduct a study to determine and set a reasonable professional dispensing fee for pharmacy providers that provide services to medicaid recipients
11
03, 2024
SB 14
An act relating to insurance; amending and enacting sections of the pharmacy benefits manager regulation act; adding new requirements for renewal of pharmacy benefits manager licenses; requiring disclosure of documents during an investigation; requiring transparency in pharmacy benefits reimbursement; providing for confidentiality; providing for changes in the reimbursement process; addressing the appeals process; requiring the provision of certain information upon request; requiring the inclusion of certain contract provisions; limiting charges to those itemized in a contract; addressing cost sharing; making an appropriation.
11
03, 2024
SB 146
An act relating to hospitals; enacting a new section of the hospital funding act to provide affordable payment plans to patients under certain circumstances.
20
02, 2024
HB 306
Relating to hospitals; requiring financial transparency reports from corporations doing business in New Mexico as hospitals or providers of management services for hospitals that seek the benefit of monetary caps on damages provided by New Mexico law; requiring the superintendent of insurance to publish reports; making an appropriation.
20
02, 2024
HB 33
Relating to prescription drugs; enacting the prescription drug price transparency act to increase transparency across the prescription drug supply chain; requiring prescription drug manufacturers, pharmacy services administrative organizations, health insurers and pharmacy benefits managers to report prescription drug price trends to the superintendent of insurance; requiring the superintendent of insurance to collect and publicly report aggregate information on prescription drug price trends; prescribing civil penalties; making an appropriation.